These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 14514582)

  • 1. Low insulin sensitivity (S(i) = 0) in diabetic and nondiabetic subjects in the insulin resistance atherosclerosis study: is it associated with components of the metabolic syndrome and nontraditional risk factors?
    Haffner SM; D'Agostino R; Festa A; Bergman RN; Mykkänen L; Karter A; Saad MF; Wagenknecht LE
    Diabetes Care; 2003 Oct; 26(10):2796-803. PubMed ID: 14514582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose.
    Festa A; D'Agostino R; Hanley AJ; Karter AJ; Saad MF; Haffner SM
    Diabetes; 2004 Jun; 53(6):1549-55. PubMed ID: 15161760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study.
    Haffner SM; D'Agostino R; Mykkänen L; Tracy R; Howard B; Rewers M; Selby J; Savage PJ; Saad MF
    Diabetes Care; 1999 Apr; 22(4):562-8. PubMed ID: 10189532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study.
    Festa A; D'Agostino R; Tracy RP; Haffner SM;
    Diabetes; 2002 Apr; 51(4):1131-7. PubMed ID: 11916936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study.
    Hanefeld M; Koehler C; Fuecker K; Henkel E; Schaper F; Temelkova-Kurktschiev T;
    Diabetes Care; 2003 Mar; 26(3):868-74. PubMed ID: 12610051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A study of the degrees of insulin resistance and first-phase insulin secretion of beta-cells in metabolic syndrome patients with different glucose tolerance].
    Hong J; Gu WQ; Zhang YF; Guo Y; Chen HM; Zhang LZ; Zhao YJ; Ning G
    Zhonghua Yi Xue Za Zhi; 2003 Nov; 83(22):1952-6. PubMed ID: 14703429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Predictors of abnormal glucose tolerance in persons at risk of type 2 diabetes: the RIAD study].
    Henkel E; Köhler C; Temelkova-Kurktschiev T; Hanefeld M
    Dtsch Med Wochenschr; 2002 May; 127(18):953-7. PubMed ID: 11987015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of future diabetes is as high with abnormal intermediate post-glucose response as with impaired glucose tolerance.
    Viswanathan V; Clementina M; Nair BM; Satyavani K
    J Assoc Physicians India; 2007 Dec; 55():833-7. PubMed ID: 18405128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of genetic prediabetic south Indian subjects. Importance of hyperinsulinemia and beta-cell dysfunction.
    Snehalatha C; Ramachandran A; Satyavani K; Latha E; Viswanathan V
    Diabetes Care; 1998 Jan; 21(1):76-9. PubMed ID: 9538973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble tumor necrosis factor-alpha receptors in young obese subjects with normal and impaired glucose tolerance.
    Dzienis-Straczkowska S; Straczkowski M; Szelachowska M; Stepien A; Kowalska I; Kinalska I
    Diabetes Care; 2003 Mar; 26(3):875-80. PubMed ID: 12610052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Singapore impaired glucose tolerance follow-up study: does the ticking clock go backward as well as forward?
    Wong MS; Gu K; Heng D; Chew SK; Chew LS; Tai ES
    Diabetes Care; 2003 Nov; 26(11):3024-30. PubMed ID: 14578234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor alpha and insulin resistance in obese type 2 diabetic patients.
    Miyazaki Y; Pipek R; Mandarino LJ; DeFronzo RA
    Int J Obes Relat Metab Disord; 2003 Jan; 27(1):88-94. PubMed ID: 12532159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in cardiovascular risk factors, insulin resistance, and insulin secretion in individuals with normal glucose tolerance and in subjects with impaired glucose regulation: the Telde Study.
    Nóvoa FJ; Boronat M; Saavedra P; Díaz-Cremades JM; Varillas VF; La Roche F; Alberiche MP; Carrillo A
    Diabetes Care; 2005 Oct; 28(10):2388-93. PubMed ID: 16186268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic predictors of impaired glucose tolerance and type 2 diabetes in a predisposed population--A prospective cohort study.
    Henninger J; Hammarstedt A; Rawshani A; Eliasson B
    BMC Endocr Disord; 2015 Sep; 15():51. PubMed ID: 26407933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of diabetes, impaired fasting glucose and insulin resistance syndrome in an urban Indian population.
    Gupta A; Gupta R; Sarna M; Rastogi S; Gupta VP; Kothari K
    Diabetes Res Clin Pract; 2003 Jul; 61(1):69-76. PubMed ID: 12849925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Insulin Resistance Atherosclerosis Study.
    Saad MF; Anderson RL; Laws A; Watanabe RM; Kades WW; Chen YD; Sands RE; Pei D; Savage PJ; Bergman RN
    Diabetes; 1994 Sep; 43(9):1114-21. PubMed ID: 8070611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin sensitivity and abdominal obesity in African-American, Hispanic, and non-Hispanic white men and women. The Insulin Resistance and Atherosclerosis Study.
    Karter AJ; Mayer-Davis EJ; Selby JV; D'Agostino RB; Haffner SM; Sholinsky P; Bergman R; Saad MF; Hamman RF
    Diabetes; 1996 Nov; 45(11):1547-55. PubMed ID: 8866560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in insulin resistance and pancreatic B-cell function in obese subjects with isolated impaired glucose tolerance and isolated impaired fasting glucose.
    Hong J; Gui MH; Gu WQ; Zhang YF; Xu M; Chi ZN; Zhang Y; Li XY; Wang WQ; Ning G
    Diabet Med; 2008 Jan; 25(1):73-9. PubMed ID: 18199133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of glucose tolerance status on PAI-1 plasma levels in overweight and obese subjects.
    Pannacciulli N; De Mitrio V; Marino R; Giorgino R; De Pergola G
    Obes Res; 2002 Aug; 10(8):717-25. PubMed ID: 12181379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin sensitivity and first-phase insulin secretion in obese Chinese with hyperglycemia in 30 and/or 60 min during glucose tolerance tests.
    Hong J; Zhang YF; Gu WQ; Zhang YW; Su YX; Chi ZN; Wang WQ; Li XY; Ning G
    Endocrine; 2008; 34(1-3):75-80. PubMed ID: 18979203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.